W. Emminger

2.0k total citations · 1 hit paper
18 papers, 1.5k citations indexed

About

W. Emminger is a scholar working on Immunology and Allergy, Dermatology and Physiology. According to data from OpenAlex, W. Emminger has authored 18 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology and Allergy, 12 papers in Dermatology and 8 papers in Physiology. Recurrent topics in W. Emminger's work include Allergic Rhinitis and Sensitization (15 papers), Dermatology and Skin Diseases (10 papers) and Food Allergy and Anaphylaxis Research (8 papers). W. Emminger is often cited by papers focused on Allergic Rhinitis and Sensitization (15 papers), Dermatology and Skin Diseases (10 papers) and Food Allergy and Anaphylaxis Research (8 papers). W. Emminger collaborates with scholars based in Denmark, United Kingdom and Germany. W. Emminger's co-authors include Ronald Dahl, Stephen R. Durham, Alexander Kapp, Jan G.R. de Monchy, S. Rak, Giselda Colombo, B.J. Riis, Jens Andersen, Glenis Scadding and Montserrat Fernández‐Rivas and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Allergy and Clinical Therapeutics.

In The Last Decade

W. Emminger

18 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial

2012 376 citations Stephen R. Durham, W. Emminger et al. Journal of Allergy and Clinical Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W. Emminger Denmark	10	1.4k	1.2k	785	159	102	18	1.5k
Hosne Ara Ferdousi Sweden	7	1.6k 1.1×	1.6k 1.3×	766 1.0×	357 2.2×	71 0.7×	8	1.7k
A. Montagut France	11	1.5k 1.0×	1.3k 1.1×	736 0.9×	181 1.1×	93 0.9×	21	1.5k
G. Barberio Italy	12	992 0.7×	749 0.6×	528 0.7×	172 1.1×	26 0.3×	30	1.1k
R. Fadel France	14	859 0.6×	841 0.7×	431 0.5×	188 1.2×	35 0.3×	27	1.0k
Christian Ljørring Denmark	7	826 0.6×	824 0.7×	388 0.5×	219 1.4×	19 0.2×	12	941
V. Di Rienzo Italy	10	559 0.4×	508 0.4×	300 0.4×	131 0.8×	21 0.2×	15	631
D R Wilson United Kingdom	5	577 0.4×	517 0.4×	330 0.4×	71 0.4×	22 0.2×	5	625
Andrea Buchmeier United States	9	489 0.3×	489 0.4×	181 0.2×	237 1.5×	30 0.3×	13	631
Anne Desroches Canada	7	531 0.4×	491 0.4×	261 0.3×	76 0.5×	16 0.2×	8	608
Sylvie Galvain France	9	891 0.6×	724 0.6×	476 0.6×	115 0.7×	30 0.3×	11	911

Countries citing papers authored by W. Emminger

Since Specialization

Citations

This map shows the geographic impact of W. Emminger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Emminger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Emminger more than expected).

Fields of papers citing papers by W. Emminger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Emminger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Emminger. The network helps show where W. Emminger may publish in the future.

Co-authorship network of co-authors of W. Emminger

This figure shows the co-authorship network connecting the top 25 collaborators of W. Emminger. A scholar is included among the top collaborators of W. Emminger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Emminger. W. Emminger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Emminger, W., Dolores Hernández Fernández de Rojas, Victòria Cardona, et al.. (2017). The SQ House Dust Mite SLIT-Tablet Is Well Tolerated in Patients with House Dust Mite Respiratory Allergic Disease. International Archives of Allergy and Immunology. 174(1). 35–44. 17 indexed citations

Kollmann, Dagmar, Birgit Nagl, C. Ebner, et al.. (2016). The quantity and quality of α-gal-specific antibodies differ in individuals with and without delayed red meat allergy. Allergy. 72(2). 266–273. 38 indexed citations

Demoly, Pascal, et al.. (2015). Effective treatment of house dust mite–induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial. Journal of Allergy and Clinical Immunology. 137(2). 444–451.e8. 160 indexed citations

Durham, Stephen R., W. Emminger, Alexander Kapp, et al.. (2012). SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial. Journal of Allergy and Clinical Immunology. 129(3). 717–725.e5. 376 indexed citations breakdown →

Reich, Kristian, Christian Geßner, Wolfgang Pohl, et al.. (2011). Immunologic Effects and Tolerability Profile of In-Season Initiation of a Standardized-Quality Grass Allergy Immunotherapy Tablet: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial in Adults with Grass Pollen–Induced Rhinoconjunctivitis. Clinical Therapeutics. 33(7). 828–840. 26 indexed citations

Durham, Stephen R., W. Emminger, Alexander Kapp, et al.. (2010). Long-term clinical efficacy in grass pollen–induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet. Journal of Allergy and Clinical Immunology. 125(1). 131–138.e7. 262 indexed citations

Durham, Stephen R., Ronald Dahl, Alexander Kapp, et al.. (2009). Sustained, disease-modifying effect of grass allergen tablet immunotherapy 1 year after completion of treatment. Data Archiving and Networked Services (DANS). 3 indexed citations

Frølund, L., Stephen R. Durham, Moisés A. Calderón, et al.. (2009). Sustained effect of SQ‐standardized grass allergy immunotherapy tablet on rhinoconjunctivitis quality of life. Allergy. 65(6). 753–757. 30 indexed citations

Szépfalusi, Zsolt, W. Emminger, Franz Eitelberger, et al.. (2009). Spezifische Immuntherapie bei IgE-vermittelten allergischen Erkrankungen im Kindes- und Jugendalter – eine Übersicht über in Österreich zugelassene/registrierte Allergenpräparate. Wiener klinische Wochenschrift. 121(19-20). 648–660. 3 indexed citations

10.

Emminger, W., S.R. Durham, B.J. Riis, Jennifer Maloney, & Hendrik Nolte. (2009). The Efficacy Of Single-grass-allergen-immunotherapy-tablet Treatment In Mono- And Multi-sensitized Allergic Rhinitis Patients: Findings From A Post Hoc Analysis. Journal of Allergy and Clinical Immunology. 123(2). S75–S75. 9 indexed citations

11.

Durham, Stephen R., Ronald Dahl, G. K. Scadding, et al.. (2009). Sustained, disease-modifying effect of grass allergy tablet immunotherapy 1 year after a 3-year treatment period. Data Archiving and Networked Services (DANS). 39(12). 1944–1944. 1 indexed citations

12.

Emminger, W., Ronald Dahl, Alexander Kapp, et al.. (2008). Continuous clinical efficacy and progressive immunological effect of long-term specific immunotherapy with the ALK grass allergen tablet : Findings from a 3-year randomised adult trial. Allergy. 63. 614–614. 2 indexed citations

13.

Dahl, Ronald, Alexander Kapp, Giselda Colombo, et al.. (2008). Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years. Journal of Allergy and Clinical Immunology. 121(2). 512–518.e2. 160 indexed citations

14.

Emminger, W., Ronald Dahl, Alexander Kapp, et al.. (2008). The Long-Term Efficacy and Safety of a Grass Allergen Tablet for Sublingual Immunotherapy: Findings from a 3-yr Clinical Trial. Journal of Allergy and Clinical Immunology. 121(2). S75–S75. 1 indexed citations

15.

Widhalm, Kurt, et al.. (2007). Malnutrition in hospitalized children aged 3-18 years. Results by using a new score in comparison with previous described scores.. Journal für Kardiologie (Krause & Pachernegg GmbH). 9(2). 13–17. 9 indexed citations

16.

Dahl, Ronald, Alexander Kapp, Giselda Colombo, et al.. (2006). Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. Journal of Allergy and Clinical Immunology. 118(2). 434–440. 336 indexed citations

17.

Dworzak, Michael, Gertraud Fröschl, Dieter Printz, et al.. (1999). Skin-associated lymphocytes in the peripheral blood of patients with atopic dermatitis: Signs of subset expansion and stimulation. Journal of Allergy and Clinical Immunology. 103(5). 901–906. 31 indexed citations

18.

Holter, Wolfgang, W. Emminger, Otto Majdic, & Walter Knapp. (1996). Enhanced production of IL4 but not of IFNλ and IL10 by peripheral blood mononuclear cells from atopic children in response to CD2 plus CD28 stimulation. Pediatric Allergy and Immunology. 7(2). 75–82. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact